Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Tonix Pharmaceuticals Holding Total Liabilities 2010-2025 | TNXP

Tonix Pharmaceuticals Holding total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
Tonix Pharmaceuticals Holding Annual Total Liabilities
(Millions of US $)
2024 $23
2023 $49
2022 $19
2021 $22
2020 $11
2019 $5
2018 $3
2017 $2
2016 $2
2015 $7
2014 $3
2013 $2
2012 $1
2011 $3
2010 $0
2009 $0
Tonix Pharmaceuticals Holding Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $12
2024-12-31 $23
2024-09-30 $21
2024-06-30 $28
2024-03-31 $27
2023-12-31 $49
2023-09-30 $18
2023-06-30 $19
2023-03-31 $14
2022-12-31 $19
2022-09-30 $14
2022-06-30 $48
2022-03-31 $16
2021-12-31 $22
2021-09-30 $13
2021-06-30 $9
2021-03-31 $7
2020-12-31 $11
2020-09-30 $5
2020-06-30 $5
2020-03-31 $3
2019-12-31 $5
2019-09-30 $2
2019-06-30 $2
2019-03-31 $2
2018-12-31 $3
2018-09-30 $2
2018-06-30 $3
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $2
2017-03-31 $2
2016-12-31 $2
2016-09-30 $3
2016-06-30 $4
2016-03-31 $4
2015-12-31 $7
2015-09-30 $5
2015-06-30 $5
2015-03-31 $4
2014-12-31 $3
2014-09-30 $4
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $2
2013-06-30 $2
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-06-30 $1
2012-03-31 $3
2011-12-31 $3
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.284B $0.010B
Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.683B 31.42
Zoetis (ZTS) United States $66.251B 24.72
Daiichi Sankyo, - (DSNKY) Japan $46.431B 23.80
Takeda Pharmaceutical (TAK) Japan $43.274B 8.83
BeOne Medicines - (ONC) Cayman Islands $32.874B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.885B 0.00
Summit Therapeutics (SMMT) United States $19.799B 0.00
Merck (MKKGY) Germany $16.472B 12.07
Shionogi (SGIOY) Japan $14.326B 14.35
Neurocrine Biosciences (NBIX) United States $13.535B 40.46
United Therapeutics (UTHR) United States $12.718B 11.01
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.553B 46.19
Grifols, S.A (GRFS) Spain $7.460B 0.00
Corcept Therapeutics (CORT) United States $7.414B 60.27
Ionis Pharmaceuticals (IONS) United States $6.903B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.436B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.277B 0.00
Hypermarcas (HYPMY) Brazil $3.066B 20.17
Crinetics Pharmaceuticals (CRNX) United States $2.737B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.596B 9.09
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.529B 13.68
NewAmsterdam Pharma (NAMS) Netherlands $2.518B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.213B 0.00
Ocular Therapeutix (OCUL) United States $1.857B 0.00
Endo (NDOI) United States $1.763B 0.00
ARS Pharmaceuticals (SPRY) United States $1.756B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.720B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
Dyne Therapeutics (DYN) United States $1.410B 0.00
Guardian Pharmacy Services (GRDN) United States $1.296B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.223B 24.46
Harrow (HROW) United States $1.199B 0.00
Ardelyx (ARDX) United States $1.038B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.035B 0.00
Collegium Pharmaceutical (COLL) United States $0.986B 5.32
Akebia Therapeutics (AKBA) United States $0.961B 0.00
Enliven Therapeutics (ELVN) United States $0.948B 0.00
Xeris Biopharma Holdings (XERS) United States $0.802B 0.00
ProKidney (PROK) United States $0.787B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.691B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
Xencor (XNCR) United States $0.621B 0.00
Zevra Therapeutics (ZVRA) United States $0.601B 0.00
Tourmaline Bio (TRML) United States $0.600B 0.00
Organogenesis (ORGO) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.563B 0.00
Theravance Biopharma (TBPH) United States $0.554B 0.00
USANA Health Sciences (USNA) United States $0.550B 11.06
Bioventus (BVS) United States $0.537B 13.62
Oruka Therapeutics (ORKA) United States $0.516B 0.00
Siga Technologies (SIGA) United States $0.477B 9.96
Savara (SVRA) United States $0.442B 0.00
Aquestive Therapeutics (AQST) United States $0.389B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.15
AleAnna (ANNA) United States $0.347B 0.00
Nanobiotix S.A (NBTX) France $0.315B 0.00
Aldeyra Therapeutics (ALDX) United States $0.302B 0.00
Altimmune (ALT) United States $0.296B 0.00
Esperion Therapeutics (ESPR) United States $0.279B 0.00
Nektar Therapeutics (NKTR) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.42
OmniAb (OABI) United States $0.238B 0.00
Larimar Therapeutics (LRMR) United States $0.229B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
MediWound (MDWD) Israel $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.204B 0.00
Lyell Immunopharma (LYEL) United States $0.184B 0.00
China SXT Pharmaceuticals (SXTC) China $0.178B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Liminatus Pharma (LIMN) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.153B 0.00
Avita Medical (RCEL) United States $0.142B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.135B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Champions Oncology (CSBR) United States $0.088B 20.03
Metagenomi (MGX) United States $0.085B 0.00
Vivani Medical (VANI) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Surrozen (SRZN) United States $0.080B 0.00
Nutriband (NTRB) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Inotiv (NOTV) United States $0.071B 0.00
Wellgistics Health (WGRX) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
DURECT (DRRX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
BioNxt Solutions (BNXTF) Canada $0.053B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 38.22
Century Therapeutics (IPSC) United States $0.049B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Mural Oncology (MURA) Ireland $0.040B 0.00
Enlivex Therapeutics (ENLV) Israel $0.036B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
FibroGen (FGEN) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Incannex Healthcare (IXHL) Australia $0.026B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.33
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.18
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00